| Authors: |
Patrikidou A; Department of Medical Oncology and Early Drug Development Department, Gustave Roussy Institute, Villejuif, France., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy., Lee-Ying R; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zarif TE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Davidsohn M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Rossetti S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Ottanelli C; University of Florence, Florence, Italy., Andrade L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Gennusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Pignata S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Ravi P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Tom Baker Cancer Centre, Calgary, Alberta, Canada., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy., Fizazi K; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it. |
